CLV - Clover Corporation Limited slow and steady movements
Shares price target around 19 per cent or $1.69
Company info.
CLV
is involved in the refining and sale of omega-3 oils and encapsulated bioactive ingredients for infant formula, children's foods, supplements and medical foods. CLV operates its businesses from five sites: a headquarter in Sydney; a manufacturing plant for tuna oils and related products in Altona; a product development R&D facility, technical support and marketing in Brisbane; the finance and IT departments in Gladstone Park; and a logistic and customer service office in the UK.
Products/services - DHA Oils:
The Company focusses on the delivery of bioactive ingredients using proprietary encapsulation technology to produce ready-to-blend products containing tuna oil and/or other nutritional lipids. Their triglyceride oil contains approximately 27% DHA and 35% total omega-3 fatty acids.
Products/services - DHA Powders:
The Company's Nu-MegaDriphorm powders utilise CSIRO's MicroMax technology under exclusive licence to microencapsulate nutritional oils. The patented technology allows up to a 50% oil payload with superior odour and taste masking. Nu-Mega Driphorm powders are used in a wide range of infant formula, follow-on formula, growing up milks and food applications.
Products/services - Microencapsulation technology:
The Company utilises a number of microencapsulation technologies that enable nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods and beverages. Developed through research and development, their proprietary technologies protect sensitive oils from oxidation allowing them to be incorporated into a range of end applications.
CLV
Homepage
Company info.
CLV
is involved in the refining and sale of omega-3 oils and encapsulated bioactive ingredients for infant formula, children's foods, supplements and medical foods. CLV operates its businesses from five sites: a headquarter in Sydney; a manufacturing plant for tuna oils and related products in Altona; a product development R&D facility, technical support and marketing in Brisbane; the finance and IT departments in Gladstone Park; and a logistic and customer service office in the UK. Products/services - DHA Oils:
The Company focusses on the delivery of bioactive ingredients using proprietary encapsulation technology to produce ready-to-blend products containing tuna oil and/or other nutritional lipids. Their triglyceride oil contains approximately 27% DHA and 35% total omega-3 fatty acids.
Products/services - DHA Powders:
The Company's Nu-MegaDriphorm powders utilise CSIRO's MicroMax technology under exclusive licence to microencapsulate nutritional oils. The patented technology allows up to a 50% oil payload with superior odour and taste masking. Nu-Mega Driphorm powders are used in a wide range of infant formula, follow-on formula, growing up milks and food applications.
Products/services - Microencapsulation technology:
The Company utilises a number of microencapsulation technologies that enable nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods and beverages. Developed through research and development, their proprietary technologies protect sensitive oils from oxidation allowing them to be incorporated into a range of end applications.
CLV
Homepage